Danaher Life Sciences - Any insider info on potential shifts?

Looking for some insight from anyone who might have a better pulse on what's going on at Danaher Life Sciences. I've been hearing rumblings, not necessarily confirmed layoffs, but significant restructuring or cost-saving measures that *could* lead to headcount reductions. It's frustrating because there's so much smoke, but no clear fire. Are there particular business units that are under more pressure? Any hints about upcoming reorganizations or strategic pivots? I'm not trying to spread unfounded rumors, but I think it's smart to be aware of potential changes in the industry and at our company. If anyone has heard anything concrete, even if it's just a heads-up about a department review or budget freeze, please share. Trying to get a clearer picture of the situation beyond the general anxiety. Thanks in advance for any genuine information you can provide.